CRNA & CAA Legislation Tracker 2026

Removes physician supervision requirement for CRNAs. Would grant full practice authority.

Impact: Would make Indiana the 26th+ full practice authority state.

Full practice authority for CRNAs with 4,000+ hours of supervised practice.

Impact: Conditional FPA after experience threshold. Compromise approach gaining traction.

Would opt Pennsylvania out of the CMS physician supervision requirement.

Impact: Significant — PA is one of the largest CRNA employers in the country.

Expand CRNA prescriptive authority to include Schedule II-V controlled substances.

Impact: Would align Ohio with states that grant full prescriptive authority to CRNAs.

Remove physician supervision requirement for CRNAs in New York.

Impact: Major impact — NY has 5,000+ CRNAs. Would dramatically change practice landscape.

Implementation of previously passed nurse practitioner FPA. CRNA-specific expansion under discussion.

Impact: California is the largest healthcare market. Any movement affects national trends.

Expand CAA practice authority and scope in Texas.

Impact: Would strengthen CAA practice in one of the largest CAA markets.

Full practice authority for CRNAs with 2 years of supervised practice.

Impact: Florida is a massive CRNA market. FPA would increase 1099 opportunities significantly.

Expand CRNA prescriptive authority.

Impact: Georgia is the largest CAA market — CRNA scope expansion has cross-professional implications.

Full practice authority for CRNAs effective July 2026.

Impact: Virginia becomes a full practice authority state. Major win for CRNA autonomy.